(Q24198036)

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB3

Influenza vaccination in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB3

Effects of upper respiratory tract infections in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB3

Acute severe deterioration in cystic fibrosis associated with influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB3

Impact of influenza on morbidity in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB3

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB3

Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB3

Antibody response to whole-virus and split-virus influenza vaccines in successful ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB3

Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB3

Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB3

Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB3

Vaccines for preventing influenza in people with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001753.PUB3

Comparison of live and inactivated influenza vaccine in high risk children

21 January 2018

1 reference

12 December 2020

The effect of respiratory viral infections on patients with cystic fibrosis

1 reference

12 December 2020

Influenza immunization in children with cystic fibrosis

1 reference

12 December 2020

Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines

1 reference

12 December 2020

Liposomal influenza vaccine

1 reference

12 December 2020

Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study

1 reference

12 December 2020

10.1002/14651858.CD001753.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

24604671

1 reference

Consolidated OpenCitations Corpus – April 2017